Cell and Gene Therapy Market Growth – at a CAGR of 19.8% During Forecast Period 2019-2027

Technological advancements in cellular and molecular biology, high prevalence of chronic and rare diseases, and increasing investments in research and development activities are some key factors expected to drive global market growth

Emergen Research has recently published its latest report titled, “Cell and Gene Therapy Market By Indication (Acute Lymphoblastic Leukemia (ALL), Inherited Retinal Disease, Large B-Cell Lymphoma, ADA-SCID), By Vector Type (Lentivirus, AAV, Retrovirus & Gammaretrovirus, Modified Herpes Simplex Virus, Adenovirus, Non-Viral Plasmid Vector), and By Region Forecast to 2027”

According to Emergen Research, the global cell and gene therapy market size was USD 1,180 Million in 2019 and is expected to reach USD 6,570 Million in 2027 and register a robust revenue CAGR of 19.8% during the forecast period, 2020-2027.

Market Dynamics: 

Cell and gene therapy are overlying fields of biomedical research and play a vital role in modern healthcare owing to benefits including cell-cell interaction, remodeling, regenerative capacity, and gene regulation. These therapies aim to prevent, treat and cure rare disorders and acquired diseases and have the potential to reduce underlying causes of these diseases.  Many leading companies are investing in research and development of gene and cell therapies. Rapid advancements in cell and gene therapy, increasing number of clinical trials, and rising demand for personalized medicine are key factors expected to drive global market revenue growth over the forecast period.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/27

Rising availability of funds and increased investments by public and private sectors to accelerate development of advanced therapies, increasing healthcare spending, and steadily improving healthcare infrastructure are expected to further fuel market growth during the forecast period. However, high costs of gene therapy and development challenges, lack of well-established healthcare facilities in many developing and underdeveloped countries, and unfavorable reimbursement schemes are some key factors that can restrain market growth during the forecast period. Moreover, limited awareness about advanced cell and gene therapies and lack of skilled labor are other factors that can hamper global cell and gene therapy market revenue growth to a certain extent over the forecast period.

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Acute Lymphoblastic Leukemia Segment Register Rapid Revenue Growth: 

The Acute Lymphoblastic Leukemia (ALL) segment is expected to register rapid revenue growth over the forecast period. This can be attributed to increasing prevalence of acute lymphoblastic leukemia across the globe, high usage of Chimeric Antigen Receptor (CAR) T-cell therapy and gene therapy, rapid advancements in cell and gene therapy, and increasing investments in cell and gene-based research. 

Retrovirus & Gammaretrovirus Segment to Account for Largest Revenue Share:

The retrovirus and gammaretrovirus segment is expected to account for largest revenue share between 2020 and 2027 owing to increasing prevalence of leukemia, rapid advancements in gene therapy, ongoing research on retrovirus and gammaretrovirus, and increasing investments in research and development activities.  

Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/27

North America to Lead in Terms of Revenue Share: 

North America is expected to dominate other regional markets in terms of revenue share during the forecast period owing to increasing prevalence of chronic and infectious diseases across the region, presence of highly developed healthcare facilities and research centers, and high healthcare expenditure. Other factors such as rising number of clinical trials related to gene therapy, presence of leading companies, and increasing investments in research and development activities are expected to fuel North America market growth during the forecast period. 

Major Companies in the Market Include:

  • Spark Therapeutics LLC
  • Novartis AG
  • Gilead Sciences Inc.
  • Bluebird Bio
  • GlaxoSmithKline
  • Celgene Corporation
  • Shire PLC
  • Sangamo Biosciences
  • Voyager Therapeutics
  • Dimension Therapeutics

For the purpose of this report, Emergen Research has segmented the global cell and gene therapy market on the basis of indication, vector type, and region:

Indication Outlook (Revenue, USD Million; 2017-2027)

  • Acute Lymphoblastic Leukemia (ALL)
  • Inherited Retinal Disease
  • Large B-Cell Lymphoma
  • Others

Vector Outlook (Revenue, USD Million; 2017-2027)

  • Lentivirus
  • AAV
  • Retrovirus & Gammaretrovirus
  • Modified Herpes Simplex Virus
  • Adenovirus
  • Non-Viral Plasmid Vector

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/cell-and-gene-therapy-market

Regional Outlook (Revenue, USD Million; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Latest Published Reports by Emergen Research:

Back and Neck Massager Market by Type (Manual Massagers, Vibrating Massagers, Impulse Massagers, Others), By Patients (Adult, Older People, Baby), By Application (Household, Hospital, Other), and By Region Forecast to 2028

USB Flashdrives Market Size, Share, Trends, By Product Type (8 GB, 16 GB, 32 GB, 64 GB, 128 GB), By Application (Personal, Commercial), By Distribution Channel (Online, Offline), and By Region Forecast to 2028

Gaming Mouse Market By Product Type (MMO Mouse, MOBA Mouse, FPS Mouse, RTS Mouse, All-Purpose Mouse), By Distribution Channel (Online, Retail Stores), By End-Use (Personal, Internet Cafe), and By Region Forecast to 2028

Top 10 Prominent Companies in the World Offering Big Data as a Service

Top 10 leading Facial Recognition Companies in the World

Top 10 Companies in the Conversational Artificial Intelligence Industry by Revenue

Top 8 Leading Companies in the Streaming Analytics Industry in the World Streaming Analytics, All You Need to Know

World Top 8 Wi-Fi as a Service (WaaS) Providers

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Our Press release@ https://www.emergenresearch.com/press-release/global-cell-and-gene-therapy-market


Back to news